Clear Labs
Automated next-generation sequencing platform for diagnostics and food safety.
Company facts
- Founded
- 2013
- Employees
- 83
- Headquarters
- United States
- CEO
- Sasan Amini
- Type
- Private
- Funding
- Series D · $30M · 2024
About
Clear Labs is at the forefront of genomic testing, dedicated to improving food safety and infectious disease diagnostics. Founded in 2014, the company has created a next-generation sequencing (NGS) platform that delivers comprehensive analyses and actionable insights to protect public health. With our advanced technology, we are transforming pathogen detection into a rapid, automated process that ensures precision and reliability. Our platform is designed to address modern challenges in public health, especially in the wake of increasing foodborne illnesses and global health crises such as the COVID-19 pandemic. Through innovative sequencing methodologies, Clear Labs enables laboratories and food producers to identify microbial threats swiftly and accurately, paving the way for effective preventive measures and controls. We are committed to making genomics accessible, facilitating a proactive approach to health and safety that empowers clients to respond to emerging pathogens effectively.